Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Lancet
    December 2021
  1. GAUDRY S, Hajage D, Dechartres A, Quenot JP, et al
    Renal replacement therapy in acute kidney injury - Authors' reply.
    Lancet. 2021;396:1975-1976.
    >> Share

  2. LU Z, Yan P, Yang K, Yao L, et al
    Renal replacement therapy in acute kidney injury.
    Lancet. 2021;396:1974-1975.
    >> Share

  3. SEPE V, Rampino T, Libetta C
    Renal replacement therapy in acute kidney injury.
    Lancet. 2021;396:1974.
    >> Share

    June 2021
  4. KALANTAR-ZADEH K, Jafar TH, Nitsch D, Neuen BL, et al
    Chronic kidney disease.
    Lancet. 2021 Jun 24. pii: S0140-6736(21)00519.
    >> Share

  5. JAFAR TH
    FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01242.
    >> Share

    April 2021
  6. LUYCKX VA, Harris DCH, Varghese C, Jha V, et al
    Bringing equity in access to quality dialysis.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00732.
    >> Share

  7. OSTERMANN M, Lumlertgul N
    Wait and see for acute dialysis: but for how long?
    Lancet. 2021;397:1241-1243.
    >> Share

  8. GAUDRY S, Hajage D, Martin-Lefevre L, Lebbah S, et al
    Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
    Lancet. 2021;397:1293-1300.
    >> Share

    September 2020
  9. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  10. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    >> Share

    July 2020
  11. REGAN J
    Collaborating on kidneys: Haiti's transplantation ambitions.
    Lancet. 2020;396:15-16.
    >> Share

    April 2020
  12. GAUDRY S, Hajage D, Benichou N, Chaibi K, et al
    Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30531.
    >> Share

  13. NIEUWENHUIJS-MOEKE GJ, Sanders JSF
    Timing of renal replacement therapy in acute kidney injury: case closed?
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30805.
    >> Share

    February 2020

  14. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2020 Feb 13. pii: S0140-6736(20)30045.
    >> Share

  15. COCKWELL P, Fisher LA
    The global burden of chronic kidney disease.
    Lancet. 2020 Feb 13. pii: S0140-6736(19)32977.
    >> Share

    January 2020
  16. HEERSPINK HJL, Parving HH, de Zeeuw D
    Atrasentan in patients with diabetes and chronic kidney disease - Authors' reply.
    Lancet. 2020;395:270.
    >> Share

  17. SEPE V, Libetta C
    Atrasentan in patients with diabetes and chronic kidney disease.
    Lancet. 2020;395:269.
    >> Share

  18. LIU D, Liu Z
    Atrasentan in patients with diabetes and chronic kidney disease.
    Lancet. 2020;395:269-270.
    >> Share

    November 2019
  19. MORATH C, Zschiedrich S, Speer C, Zeier M, et al
    Clinical outcomes after ABO-incompatible renal transplantation.
    Lancet. 2019;394:1989.
    >> Share

  20. SCURT FG, Mertens PR, Chatzikyrkou C
    Clinical outcomes after ABO-incompatible renal transplantation - Authors' reply.
    Lancet. 2019;394:1989-1990.
    >> Share

  21. LOUPY A, Bouquegneau A, Stegall MD, Montgomery RA, et al
    Clinical outcomes after ABO-incompatible renal transplantation.
    Lancet. 2019;394:1988-1989.
    >> Share

    September 2019
  22. AGARWAL R, Rossignol P, Romero A, Garza D, et al
    Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2019 Sep 13. pii: S0140-6736(19)32135.
    >> Share

    June 2019
  23. WESSON DE, Mathur V, Tangri N, Stasiv Y, et al
    Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
    Lancet. 2019 Jun 24. pii: S0140-6736(19)31388.
    >> Share

    April 2019
  24. CURRIE IS, Henderson LK
    ABO-incompatible renal transplantation.
    Lancet. 2019 Apr 18. pii: S0140-6736(19)30296.
    >> Share

  25. SCURT FG, Ewert L, Mertens PR, Haller H, et al
    Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.
    Lancet. 2019 Apr 18. pii: S0140-6736(18)32091.
    >> Share

  26. PAN D, Arkell P, Stone NRH, Parkinson B, et al
    Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids.
    Lancet. 2019;393:1536.
    >> Share

  27. TUTTLE KR
    A turning point for chronic kidney disease in diabetes.
    Lancet. 2019 Apr 12. pii: S0140-6736(19)30855.
    >> Share

  28. HEERSPINK HJL, Parving HH, Andress DL, Bakris G, et al
    Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
    Lancet. 2019 Apr 12. pii: S0140-6736(19)30772.
    >> Share

    March 2019
  29. WESSON DE, Mathur V, Tangri N, Stasiv Y, et al
    Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32562.
    >> Share

    February 2019
  30. JORDAN SC
    Immune response to non-HLA antigens and renal allograft loss.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)33186.
    >> Share

    January 2017
  31. MANOOK M, Koeser L, Ahmed Z, Robb M, et al
    Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.
    Lancet. 2017 Jan 5. pii: S0140-6736(16)31595.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016